Compounds having the formula (I), ##STR1## are useful as serine protease inhibitors, more particularly inhibitors of Factors VIIa, IXa, Xa, and/or XIa, wherein ring B is phenyl or pyridyl, W is preferably C(.dbd.O)NR.sub.4 R.sub.5, L is a linker group, X.sub.2 comprises nitrogen or carbon, Z is an optionally-substituted monocyclic or bicyclic ring system, and R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are as defined in the specification.

Combina ter a fórmula (i), ## do ## STR1 são útil como inibidores do protease do serine, mais particularmente inibidores dos fatores VIIa, IXa, Xa, e/ou XIa, wherein o anel B é phenyl ou pyridyl, W é preferivelmente C(.dbd.O)NR.sub.4 R.sub.5, L é um grupo do linker, X.sub.2 compreende o nitrogênio ou o carbono, Z é um sistema monocyclic ou bicyclic opcional-substituído do anel, e R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 e R.sub.6 são como definidos na especificação.

 
Web www.patentalert.com

< Compositions and methods of treatment of sympathetically maintained pain

< Method for the iontophoretic non-invasive determination of the in vivo concentration level of an inorganic or organic substance

> Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones

> 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents

~ 00089